BILL · 2023–24 SESSION

SB 6182: Obesity Rx coverage

Providing prescription drug coverage for the treatment of obesity.

Summary

  • Requires health plans offered to public employees and their covered dependents issued or renewed on or after January 1, 2025, and Medicaid managed care organizations to provide prescription drug coverage for glucagon-like peptide 1 agonists and other similar medications when prescribed by a health care provider for the treatment of obesity if the patient meets the requirements.

From the Senate Bill Report (SB 6182), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 11, 2024
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Senator (R-18)
Introduced
January 11, 2024 in the Senate
Last action
January 11, 2024
Budget
Has a fiscal note

AN ACT Relating to providing prescription drug coverage for the treatment of obesity;

Sponsors

Prime sponsor: Senator (R-18)

3 co-sponsors (2 Democrats, 1 Republican)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. First reading, referred to Health & Long Term Care.

SB 6182 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page